260 related articles for article (PubMed ID: 31135294)
1. 2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-sectional Imaging.
Lee SI; Atri M
Radiology; 2019 Jul; 292(1):15-24. PubMed ID: 31135294
[TBL] [Abstract][Full Text] [Related]
2. Multimodality Imaging of Uterine Cervical Malignancies.
Mansoori B; Khatri G; Rivera-Colón G; Albuquerque K; Lea J; Pinho DF
AJR Am J Roentgenol; 2020 Aug; 215(2):292-304. PubMed ID: 32551909
[No Abstract] [Full Text] [Related]
3. Implications of the new FIGO staging and the role of imaging in cervical cancer.
Kido A; Nakamoto Y
Br J Radiol; 2021 Sep; 94(1125):20201342. PubMed ID: 33989030
[TBL] [Abstract][Full Text] [Related]
4. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA
Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT in the evaluation of cancer cervix: Where do we stand today?
Palaniswamy SS; Borde CR; Subramanyam P
Nucl Med Commun; 2018 Jul; 39(7):583-592. PubMed ID: 29683929
[TBL] [Abstract][Full Text] [Related]
6. Imaging Biomarkers and Liquid Biopsy in Assessment of Cervical Cancer.
Ghani MA; Liau J; Eskander R; Mell L; Yusufaly T; Obrzut S
J Comput Assist Tomogr; 2022 Sep-Oct 01; 46(5):707-715. PubMed ID: 35995483
[TBL] [Abstract][Full Text] [Related]
7. What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?
Haldorsen IS; Lura N; Blaakær J; Fischerova D; Werner HMJ
Curr Oncol Rep; 2019 Jul; 21(9):77. PubMed ID: 31359169
[TBL] [Abstract][Full Text] [Related]
8. Imaging and Staging of Cervical Cancer.
Devine C; Viswanathan C; Faria S; Marcal L; Sagebiel TL
Semin Ultrasound CT MR; 2019 Aug; 40(4):280-286. PubMed ID: 31375168
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
[TBL] [Abstract][Full Text] [Related]
10. Comparison of
Sarabhai T; Schaarschmidt BM; Wetter A; Kirchner J; Aktas B; Forsting M; Ruhlmann V; Herrmann K; Umutlu L; Grueneisen J
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):67-76. PubMed ID: 28840302
[TBL] [Abstract][Full Text] [Related]
11. MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls.
Balcacer P; Shergill A; Litkouhi B
Abdom Radiol (NY); 2019 Jul; 44(7):2557-2571. PubMed ID: 30903231
[TBL] [Abstract][Full Text] [Related]
12. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
Fischerová D; Cibula D
Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
[TBL] [Abstract][Full Text] [Related]
13. Pelvic lymph node status assessed by 18F-fluorodeoxyglucose positron emission tomography predicts low-risk group for distant recurrence in locally advanced cervical cancer: a prospective study.
Kang S; Park JY; Lim MC; Song YJ; Park SH; Kim SK; Chung DC; Seo SS; Kim JY; Park SY
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):788-93. PubMed ID: 20452133
[TBL] [Abstract][Full Text] [Related]
14. Nuclear imaging and cervical cancer.
Grigsby PW
Minerva Ginecol; 2009 Feb; 61(1):45-51. PubMed ID: 19204660
[TBL] [Abstract][Full Text] [Related]
15. (18)F-FDG PET/CT can correct the clinical stages and predict pathological parameters before operation in cervical cancer.
Yang Z; Xu W; Ma Y; Liu K; Li Y; Wang D
Eur J Radiol; 2016 May; 85(5):877-84. PubMed ID: 27130046
[TBL] [Abstract][Full Text] [Related]
16. Cervical tumors.
Sahdev A
Semin Ultrasound CT MR; 2010 Oct; 31(5):399-413. PubMed ID: 20974359
[TBL] [Abstract][Full Text] [Related]
17. Detection of distant metastatic disease by positron emission tomography with
Lin A; Ma S; Dehdashti F; Markovina S; Schwarz J; Siegel B; Powell M; Grigsby P
Int J Gynecol Cancer; 2019 Mar; 29(3):487-491. PubMed ID: 30739082
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.
Morkel M; Ellmann A; Warwick J; Simonds H
Int J Gynecol Cancer; 2018 Feb; 28(2):379-384. PubMed ID: 29324535
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
Cima S; Perrone AM; Castellucci P; Macchia G; Buwenge M; Cammelli S; Cilla S; Ferioli M; Ferrandina G; Galuppi A; Salizzoni E; Rubino D; Fanti S; De Iaco P; Morganti AG
Int J Gynecol Cancer; 2018 Mar; 28(3):575-580. PubMed ID: 29372911
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer - staging and restaging with 18F-FDG PET/CT.
Brito AET; Matushita C; Esteves F; Gomes G; Bernardo WM; Amorim BJ
Rev Assoc Med Bras (1992); 2019 May; 65(4):568-575. PubMed ID: 31066810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
